Predictors of long-term neutralizing antibody titers following COVID-19 vaccination by three vaccine types: the BOOST study
Aric A. Prather(University of California, San Francisco), Elissa Epel(University of California, San Francisco), Stacy S. Drury(Boston Children's Hospital), Ashley E. Mason(University of California, San Francisco), Frederick Hecht(University of California, San Francisco), Elizabeth H. Blackburn(Rutgers, The State University of New Jersey), Jue Lin(University of California, San Francisco), Ethan G. Dutcher(University of Cambridge), Julia O’Bryan, James E. Robinson(Tulane University), Elena Fromer, Bresh Merino, Remi Frazier(University of California, San Francisco)
Cited by 34
Related Papers
Microbial translocation is a cause of systemic immune activation in chronic HIV infection
|Nature Medicine|2006|3.6k
Adherence to protease inhibitors, HIV-1 viral load, and development of drug resistance in an indigent population
|AIDS|2000|1k
Immune activation set point during early HIV infection predicts subsequent CD4+ T-cell changes independent of viral load
|Blood|2004|787
Tryptophan Catabolism by Indoleamine 2,3-Dioxygenase 1 Alters the Balance of T <sub>H</sub> 17 to Regulatory T Cells in HIV Disease
|Science Translational Medicine|2010|514
Increased telomerase activity and comprehensive lifestyle changes: a pilot study
|The Lancet Oncology|2008|431